What is Global Longlife Hospital and Research Ltd (543520) share price return in the past 10 years?

Data is not available for this company

What is the share price of Global Longlife Hospital and Research Ltd (543520)?

Company share prices are keep on changing according to the market conditions. The current trading price of Global Longlife Hospital and Research Ltd (543520) on 24-Jun-2026 16:59:59 at 16:59 is 10.38.

What is the P/E ratio of Global Longlife Hospital and Research?

The latest standalone P/E ratio of Global Longlife Hospital and Research as of 24-Jun-2026 is 0.00.

What is the P/B ratio of Global Longlife Hospital and Research Ltd (543520)?

The latest standalone P/B ratio of Global Longlife Hospital and Research Ltd (543520) as of 24-Jun-2026 is 0.48.

What is the 52-week high and low of Global Longlife Hospital and Research Ltd (543520)?

The 52-week high of Global Longlife Hospital and Research Ltd (543520) is Rs. 26.73 and the 52-week low is Rs. 9.74.

Global Longlife Hospital and Research Ltd (543520) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Global Longlife Hospital and Research Ltd (543520)
Brand: Global Longlife Hospital and Research

Global Longlife Hospital and Research Ltd (543520)

Key Metrics

Valuation Multiples

Market Cap

₹11 Cr.

Current Price

₹10.4

52-Week Low / High

₹10 / 27

TTM EPS

₹-1.6

TTM Sales

₹0 Cr.

Book Value per Share

₹21.6

P/E Ratio

0.00

Lower than its 5-year historical median

Industry PE

91.4

Price to Book (P/B)

0.48

Lower than its 5-year historical median

Price to Sales (P/S)

0.00

Lower than its 5-year historical median

EV/EBITDA

6.19

Lower than its 5-year historical median

Dividend Yield

Profitability Efficiency

Return on Equity (ROE)

-7.22%

Underperforms industry median

Return on Capital Employed (ROCE)

-4.15%

Underperforms industry median

Return on Assets (ROA)

-7.49%

Operating Profit Margin

Net Profit Margin

Gross Profit Margin

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Steady versus 3-year growth rate

-100%

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

-960%

Asset Quality

Promoter Holding

22.88%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹13 Cr.

Equity

₹10.5 Cr.

Face Value

₹10

All Time Low / High

₹9.74 / 141.10

Global Longlife Hospital and Research stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Global Longlife Hospital and Research Ltd a good quality company?

Global Longlife Hospital and Research Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Global Longlife Hospital and Research Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Global Longlife Hospital and Research Ltd vs industry peers?

Global Longlife Hospital and Research Ltd revenue CAGR is -55.58%, compared to the industry median CAGR of 1.38%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Global Longlife Hospital and Research Ltd?

Promoters hold 22.88% of the Global Longlife Hospital and Research Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Global Longlife Hospital and Research Ltd over the last decade?

Over the last 3 year(s), the stock has delivered a CAGR of -35.91% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26	TTM
ROCE % ⓘ	12.1%	3.7%	13.5%	29.4%	6.7%	-2.8%	1.3%	-4.2%	-
Value Creation Index ⓘ	-0.1	-0.7	0.0	1.1	-0.5	-1.2	-0.9	-1.3	-
Growth Parameters ⓘ
Sales ⓘ	34.5	33.5	32.7	32.8	23.5	13.5	0.6	0	0
Sales YoY Gr.	-	-2.9%	-2.5%	0.4%	-28.4%	-42.5%	-95.7%	-100%	-
Adj EPS ⓘ	2	-1.2	2.9	5.2	1.7	-2.1	-2.7	-1.6	-1.6
YoY Gr.	-	-163.1%	NA	77.1%	-66.3%	-217.8%	NA	NA	-
BVPS (₹) ⓘ	0	0	14.5	20	58.9	22.6	23.8	21.6	21.6
Adj Net Profit ⓘ	1.4	-0.9	2.1	3.6	1.8	-2.2	-2.8	-1.7	-2
Cash Flow from Ops. ⓘ	5.4	3.9	6.9	9.4	-40.4	-5.1	12.3	-4.5	-
Debt/CF from Ops. ⓘ	5	6	2.5	0.9	-0.2	-2.5	0	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	-100%	-100%	-100%
Adj EPS ⓘ	NA	-189.1%	-198.1%	NA
BVPSⓘ	NA	8.3%	-28.5%	-9.3%
Share Price	-	-	-36.2%	-56.3%

Key Financial Parameters ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26	TTM
Return on Equity % ⓘ	11.1	-7.2	16.3	23.6	4.5	-4.8	-10.7	-6.8	-7.6
Op. Profit Mgn % ⓘ	19.5	10.1	16.6	25.3	17.3	-1.8	-717.1	0	NAN
Net Profit Mgn % ⓘ	4	-2.6	6.3	11	7.8	-15.9	-488.4	0	-INF
Debt to Equity ⓘ	2.2	2.1	1.7	0.6	0.2	0.5	0	0	-
Working Cap Days ⓘ	0	206	165	125	478	942	6,575	0	0
Cash Conv. Cycle ⓘ	0	56	33	43	103	121	722	0	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Sales	34.54	33.54	32.70	32.82	23.50	13.51	0.58	0
Operating Expenses ⓘ +	27.79	30.16	27.27	24.58	19.43	13.82	4.72	0.99
Manufacturing Costs	15.12	19.52	13.52	14.21	9.71	7.84	1.90	0
Material Costs	4.34	5.06	8.59	3.60	4.33	1.22	0.44	0
Employee Cost	4.28	4.06	3.42	3.52	3.03	2.74	0.57	0.01
Other Costs ⓘ	4.05	1.51	1.74	3.25	2.36	2.02	1.81	0.98
Operating Profit ⓘ	6.75	3.39	5.44	8.23	4.07	-0.30	-4.14	-0.99
Operating Profit Margin (%)	19.5%	10.1%	16.6%	25.1%	17.3%	-2.2%	-717.0%	-
Other Income ⓘ +	0.19	0.11	0.06	0.23	0.24	0.06	5.02	0.01
Exceptional Items ⓘ	0	0	0	0	0	0	0	0
Interest ⓘ	2.09	2.44	2.43	1.61	0.43	0.78	0.30	0
Depreciation ⓘ	2.15	2.13	1.31	1.14	1.17	1.25	0.48	0
Profit Before Tax ⓘ	2.69	-1.06	1.76	5.71	2.71	-2.27	0.10	-0.99
Tax ⓘ	1.32	-0.20	-0.29	2.14	0.88	-0.08	-0.10	0.73
Profit After Tax	1.36	-0.86	2.05	3.57	1.83	-2.19	0.20	-1.72
PAT Margin (%)	4.0%	-2.6%	6.3%	10.9%	7.8%	-16.2%	34.4%	-
Adjusted EPS (₹)	2.0	-1.2	2.9	5.1	1.7	-2.1	0.2	-1.6
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Global Longlife Hosp - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Equity and Liabilities
Shareholders Fund +	12.35	11.49	13.68	16.96	64.29	25.93	26.79	23.75
Share Capital ⓘ	7	7	7	7	10.50	10.50	10.50	10.50
Reserves ⓘ	5.35	4.49	6.68	9.96	53.79	15.43	16.29	13.25
Debt +	23.55	22.91	15.32	-0.99	9.14	11.78	0	0
Long Term Debt	17.72	16.89	12.51	2.82	3.64	3.41	0	0
Short Term Debt	5.83	6.03	2.81	-3.81	5.50	8.37	0	0
Minority Interest	0	0	0	0	0	0	0	0
Trade Payables	2.74	5.43	3.26	4.28	1.31	2.56	0	0
Others Liabilities ⓘ	1.47	-1.30	0.76	11.15	-0.95	-0.76	-2.29	-2.34
Total Liabilities ⓘ	40.12	38.53	33.02	31.40	73.79	39.51	24.50	21.41
Fixed Assets
Net Fixed Assets ⓘ +	20.17	18.72	17.46	16.71	16.52	17.27	0	0
Gross Block	21.74	20.27	25.74	26.14	27.11	29.02	0	0
Accumulated Depreciation	1.58	1.55	8.28	9.42	10.59	11.75	0	0
CWIP ⓘ	0	0	0	0	1.03	0	0	0
Investments ⓘ	0.10	0.10	0.47	0.10	0.10	0.03	0.03	0
Inventories	2.02	2.19	0.81	0.88	0.82	0.44	0	0
Trade Receivables	8.69	6.27	7.84	8.91	9.70	1.95	0.32	0.23
Cash Equivalents ⓘ	0.48	1.29	0.44	0.22	3.60	0.39	21.49	17.02
Others Assets ⓘ	8.66	9.96	6	4.58	42.03	19.44	2.65	4.17
Total Assets ⓘ	40.12	38.53	33.02	31.40	73.79	39.51	24.50	21.41

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Cash Flow From Operating Activity ⓘ +	5.40	3.90	6.88	9.42	-40.42	-5.07	12.32	-4.51
PBT ⓘ	2.69	-1.06	1.76	5.71	2.71	-2.27	0.10	-0.99
Adjustment ⓘ	4.16	4.47	4.10	2.89	2.02	-33.58	-2.92	-0.62
Changes in Working Capital ⓘ	-1.44	0.49	1.02	0.16	-43.87	30.87	15.4	-2.4
Tax Paid ⓘ	0	0	0	0.67	-1.27	-0.10	-0.26	-0.50
Cash Flow From Investing Activity ⓘ +	-0.33	-0.04	0.02	0.01	-1.90	-0.82	21.80	0.04
Capex	-0.40	-0.11	-0.04	-0.46	-2	-1.03	21.10	0
Net Investments	0	0	0	0.27	-0.02	0.15	0.57	0.03
Others ⓘ	0.07	0.07	0.06	0.20	0.12	0.06	0.13	0.01
Cash Flow From Financing Activity ⓘ +	-4.77	-3.05	-7.22	-9.66	45.70	2.67	-13.01	-0
Net Proceeds from Shares ⓘ	2	0	0	0	45.50	0	0	0
Net Proceeds from Borrowing ⓘ	-3.44	-0.83	-4.94	-9.69	0.82	-0.23	-3.41	0
Interest Paid ⓘ	-2.07	-2.41	-2.28	-1.31	-0.40	-0.77	-0.28	-0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0
Others ⓘ	-1.26	0.19	0	1.34	-0.22	3.67	-9.33	0
Net Cash Flow ⓘ	0.31	0.81	-0.33	-0.22	3.38	-3.22	21.11	-4.47

Financial Ratio

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Ratios
ROE (%)	11.05	-7.23	18.94	29.65	4.82	-5.11	0.82	-7.22
ROCE (%)	12.09	3.69	13.49	29.36	6.69	-2.77	1.28	-4.15
Asset Turnover Ratio	0.86	0.85	0.91	1.02	0.45	0.24	0.02	0
PAT to CFO Conversion(x)	3.97	N/A	3.36	2.64	-22.09	N/A	61.6	N/A
Working Capital Days
Receivable Days	91.90	81.40	78.70	93.10	144.50	157.20	716.70	0
Inventory Days	21.30	22.90	16.80	9.40	13.20	16.90	0	0
Payable Days	230.60	294.80	184.80	381.80	235.50	578.80	1,068.10	0

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Global Longlife Hospital and Research Ltd FAQs

The current trading price of Global Longlife Hosp on 24-Jun-2026 16:59 is ₹10.38.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 23-Jun-2026 the market cap of Global Longlife Hosp stood at ₹10.90 Cr

The latest P/E ratio of Global Longlife Hosp as of 23-Jun-2026 is 0.00.

The latest P/B ratio of Global Longlife Hosp as of 23-Jun-2026 is 0.48.

The 52-week high of Global Longlife Hosp is ₹26.73 and the 52-week low is ₹9.74.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Global Longlife Hosp is ₹0.00 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Global Longlife Hospital and Research Ltd is a below average quality company.

The key valuation ratios of Global Longlife Hospital and Research Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Global Longlife Hospital and Research Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Global Longlife Hospital and Research Ltd

Global Longlife Hospital and Research is known as a Multi Speciality Tertiary Care Hospital of Gujarat with many beds well equipped for Medical & Surgical Specialities. It provides platform to the doctors for treatment of their patients. The company has adopted the Standard Operating Procedures (SOPs) given by Ministry of Health & Family Welfare. Under the said SOPs every work function of its hospital is defined, every process is written down and every employee is trained in his/her duties as soon as he/she joins. Every equipment is maintained as per a predefined schedule. Every necessary license is obtained and renewed as required time to time. The company is certified by National Accreditation Board for Hospitals and Healthcare Providers (NABH Accredited) which is committed to support improvement of quality of healthcare service in its country for all strata of the population through various methodologies and tools to supplement the efforts of the providers of healthcare service and the requirements of the system at various levels. The main purpose of the company’s promoter is to serve the people, hence, the company is also following the same path for which it put its ethics above the all cost. Through the Mukhya Mantri Amrutum Yojana the company has served over 6,000 patients up till now.

The company has invested in, and have established a IT system both for clinical purposes as well as integrating systems and processes through HMS (Hospital Management System)which includes Central Registration module, Appointment, Barcode Generation, Case Paper Generation, OPD Billing, Procedure billing, IPD Registration, Advance & Refund, Due billing, TPA/Package Billing, User Management, Doctor Sharing, Software Security, Management Reports, Discharge Summary towards streamlining its clinical and administrative functions. It has adopted technology with a view to ensure quick transmission of disease data, subsequent analysis, and prompt disease management.

Business area of the company

The company provides health care services. The company offers Oncology, Ophthalmology, Cardiology, Dermatology, Gynecology, Spine Surgery, Plastic Surgery, Ultrasound, Microbiology, Dialysis, and Physiotherapy among other healthcare services. Global Longlife Hospital is certified by the National Accreditation Board for Hospitals and Healthcare Providers (NABH Accredited).

Major Events, Key Awards, Accreditations or Recognition

2016: The company has received Leadership award of ‘Best emerging hospital of India’ by The Associated Chambers of Commerce and Industry of India.
2018: The company has received ‘Global Achievers Awards For Health Excellence’ for outstanding achievement in Health and Social Services at 12th International Achievers on 'Global Business Opportunities', Dubai, UAE.
2018: Certificate of Recognition as ‘Times Health Icon’ by Times Health Icon 2018 - A Times Group Company.
2021: Certificate of Recognition as ‘Most Trusted Hospital’ by Times Healthcare Leaders Ahmedabad, 2021 - A Times Group Company.

Global Longlife Hospital and Research Ltd (543520)

Global Longlife Hospital and Research Ltd (543520)

Global Longlife Hospital and Research stock performance